Towards more effective treatment for multiple myeloma

SUNY downstate researchers find protein inhibitor has potent anti-tumor effects

2012-01-10

(Press-News.org) A new study from SUNY Downstate Medical Center in Brooklyn, New York, shows that MAL3-101, a recently developed inhibitor of the heat shock protein 70 (Hsp70), appears to have potent anti-tumor effects on multiple myeloma, a bone marrow cancer. Despite aggressive modes of treatments, myeloma ultimately remains incurable. The disease has a high incidence in the communities served by SUNY Downstate.

The findings, published in a recent issue of Journal of Oncology, are the result of a collaborative effort among researchers working in the laboratory of Olcay Batuman, MD, at Downstate; scientists at the University of Pittsburgh, where the small molecule inhibitor MAL3-101 was developed; scientists at the University of California at San Francisco; and other collaborators at SUNY Downstate.

Multiple myeloma is characterized by an accumulation and expansion of neoplastic plasma cells in the bone marrow. Normally, these white blood cells manufacture the antibodies needed to fight infection. When plasma cells become cancerous, however, they invade the bone marrow and the skeleton, and the immune system is severely compromised. Skeletal fragility, fatigue, weight loss, kidney failure, and repeated infections are common key manifestations and causes of morbidity and mortality from multiple myeloma. The risk for developing this disease increases with age.

"Currently multiple myeloma remains an incurable disease, despite the use of stem cell transplants, high-dose chemotherapy, and radiation," explains Dr. Batuman, professor of medicine and cell biology at Downstate and head of the research team that conducted the study. "New treatment modalities are urgently needed," she says.

The study aimed to explore the cytotoxic effects of MAL3-101 on multiple myeloma tumor growth. The researchers found that MAL3-101 exhibited anti-myeloma effects both in vitro and in vivo on tumor cell lines, as well as on primary tumor and endothelial cells from patients. When used in animal studies with the proteasome inhibitor bortezomib, MAL3-101 significantly boosted its anti-myeloma effects. Dr. Batuman's team found that by targeting Hsp70 activity, the dosage of synergic agents such as bortezomib could be reduced without compromising their effectiveness. The ability to reduce dosage makes it possible to continue the use of drugs that are toxic at higher concentrations. The addition of new synergistic agents also enriches the treatment arsenal by reducing drug resistance.

"The results of our study are very encouraging," says Dr. Batuman. "While this is not a cure and it will be some time before the compound is developed as a drug, we believe that MAL3-101, when used synergistically with existing therapies, could reduce overall drug concentrations and avoid treatment resistance."

Dr. Batuman adds, "It is possible to speculate that MAL3-101 may also modulate development of the multiple myeloma cancer stem cell. The relapse of multiple myeloma in patients in whom complete remission had been achieved is currently thought to indicate the presence of treatment-resistant multiple myeloma cancer stem cells. At Downstate, a group effort is now geared towards identifying and targeting these cancer stem cells in multiple myeloma. The anti-myeloma effects of MAL3-101 could include inhibition of cancer stem cell development, since the Hsp-70 function is required in early plasma cell development. Our prediction is that antagonism of the Hsp-70 chaperone or chaperones by affecting non-redundant pathways could be effective in multiple myeloma treatment."

### SUNY Downstate Medical Center, founded in 1860, was the first medical school in the United States to bring teaching out of the lecture hall and to the patient's bedside. A center of innovation and excellence in research and clinical service delivery, SUNY Downstate Medical Center comprises a College of Medicine, Colleges of Nursing and Health Related Professions, a School of Graduate Studies, a School of Public Health, University Hospital of Brooklyn, and an Advanced Biotechnology Park and Biotechnology Incubator.

SUNY Downstate ranks ninth nationally in the number of alumni who are on the faculty of American medical schools. More physicians practicing in New York City have graduated from SUNY Downstate than from any other medical school.

ELSE PRESS RELEASES FROM THIS DATE:

ORNL experiments prove nanoscale metallic conductivity in ferroelectrics

2012-01-10

OAK RIDGE, Tenn -- The prospect of electronics at the nanoscale may be even more promising with the first observation of metallic conductance in ferroelectric nanodomains by researchers at Oak Ridge National Laboratory. Ferroelectric materials, which switch their polarization with the application of an electric field, have long been used in devices such as ultrasound machines and sensors. Now, discoveries about ferroelectrics' electronic properties are opening up possibilities of applications in nanoscale electronics and information storage. In a paper published in ...

Clearest picture yet of dark matter points the way to better understanding of dark energy

2012-01-10

BATAVIA, Illinois, and BERKELEY, California –Two teams of physicists at the U.S. Department of Energy's Fermilab and Lawrence Berkeley National Laboratory (Berkeley Lab) have independently made the largest direct measurements of the invisible scaffolding of the universe, building maps of dark matter using new methods that, in turn, will remove key hurdles for understanding dark energy with ground-based telescopes. The teams' measurements look for tiny distortions in the images of distant galaxies, called "cosmic shear," caused by the gravitational influence of massive, ...

Getting cancer cells to swallow poison

2012-01-10

BOSTON, MA -- Honing chemotherapy delivery to cancer cells is a challenge for many researchers. Getting the cancer cells to take the chemotherapy "bait" is a greater challenge. But perhaps such a challenge has not been met with greater success than by the nanotechnology research team of Omid Farokhzad, MD, Brigham and Women's Hospital (BWH) Department of Anesthesiology Perioperative and Pain Medicine and Research. In their latest study with researchers from Massachusetts Institute of Technology (MIT) and Massachusetts General Hospital, the BWH team created a drug delivery ...

San Diego Fire-Flood-Mold Recovery Firm Renews National Affiliation

2012-01-10

Superior Restoration announced today it has renewed its partnership with Disaster Kleenup International (DKI), LLC, North America's largest disaster restoration contracting organization. Superior Restoration is San Diego's premier disaster cleanup and construction firm, providing 24-hour water damage restoration, fire damage repair and mold remediation services. By renewing its DKI membership, Superior Restoration will continue to utilize DKI's 24-hour call center, its DIAMOND claims tracking technology, and other tools to enhance its ability to serve its insurance and ...

Queen's researchers shed light on how children learn to speak

2012-01-10

Researchers have discovered that children under the age of two control speech using a different strategy than previously thought. During the study at Queen's University, the researchers changed the vowel sounds that the participants heard over headphones as they talked. They found that while the adults and young children changed their vowel sounds in response to this altered feedback, the toddlers did not. "We were very surprised to find that the two-year-olds do not monitor their own voice when speaking in the same way as adults do," says Ewen MacDonald, a former Queen's ...

Hopkins researchers find 'Google Flu Trends' a powerful early warning system for emergency departments

2012-01-10

Monitoring Internet search traffic about influenza may prove to be a better way for hospital emergency rooms to prepare for a surge in sick patients compared to waiting for outdated government flu case reports. A report on the value of the Internet search tool for emergency departments, studied by a team of researchers at Johns Hopkins Medicine over a 21-month period, is published in the January 9 issue of Clinical Infectious Diseases. The researchers reported a strong correlation between a rise in Internet searches for flu information, compiled by Google's Flu Trends ...

HIE Debate Continues Between Public and Private Models

2012-01-10

KLAS reports that while providers are juggling a laundry list of priorities--meaningful use, ICD-10, RAC audits, and accountable care models, HIEs are still of high interest to many providers. In the report, "HIE Perception 2011: Public or Private?" KLAS interviewed 96 healthcare executives to uncover which HIE vendors were selected in 2011 and why. "There's still an ocean of options out there," says Mark Allphin, report author, "and with all the market hype it's still hard to see which vendors are really cresting to the top. What we are really ...

Pill some day may prevent serious foodborne illness, scientist says

2012-01-10

WEST LAFAYETTE, Ind. - Modified probiotics, the beneficial bacteria touted for their role in digestive health, could one day decrease the risk of Listeria infection in people with susceptible immune systems, according to Purdue University research. Arun Bhunia, a professor of food science; Mary Anne Amalaradjou, a Purdue postdoctoral researcher; and Ok Kyung Koo, a former Purdue doctoral student, found that the same Listeria protein that allows the bacteria to pass through intestinal cells and into bloodstreams can help block those same paths when added to a probiotic. "Based ...

Heart attack risk rises after loss of loved one

2012-01-10

BOSTON – A person's risk of suffering a heart attack increases by approximately 21 times in the first 24 hours after losing a loved one, according to a study lead by researchers at Beth Israel Deaconess Medical Center. The study published Jan. 9 online in the journal Circulation found the risk of heart attack remained eight times above normal during the first week after the death of a loved one, slowly declining, but remaining elevated for at least a month. Researchers interviewed approximately 2,000 patients who suffered myocardial infarctions, or heart attacks, over ...

Superenalotto in Italy is Now Considered One of the Largest Jackpot Games in the World

2012-01-10

Superenalotto opened in Italy in late 1997 and hasn't looked back. The lotto game is now considered one of the largest jackpot games in the world, plus it's played by millions of people from many different European countries. The Italy SuperStar estimated jackpot for the upcoming drawing on January 7th is EUR 50,500,000 which is higher than any other country in the world. Because of the popularity of Superenalotto it is now possible for people from other countries to purchase the lottery tickets online through various lottery websites. This lottery game is also one ...

Towards more effective treatment for multiple myeloma

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: